These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 2118323

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
    Lavoie SR, Wong ES, Coudron PE, Williams DS, Markowitz SM.
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antimicrobial susceptibility and molecular epidemiology of beta-lactamase-producing, aminoglycoside-resistant isolates of Enterococcus faecalis.
    Markowitz SM, Wells VD, Williams DS, Stuart CG, Coudron PE, Wong ES.
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1075-80. PubMed ID: 1929246
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.
    Hindes RG, Willey SH, Eliopoulos GM, Rice LB, Eliopoulos CT, Murray BE, Moellering RC.
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1019-22. PubMed ID: 2506803
    [Abstract] [Full Text] [Related]

  • 9. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM, García-de-la-Mària C, Brunet M, Armero Y, García-González J, Casals G, Almela M, Quintana E, Falces C, Ninot S, Fuster D, Llopis J, Marco F, Moreno A, Miró JM, Hospital Clinic Endocarditis Study Group.
    J Antimicrob Chemother; 2017 Jun 01; 72(6):1714-1722. PubMed ID: 28204495
    [Abstract] [Full Text] [Related]

  • 10. Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.
    Perdikaris GS, Pefanis A, Giamarellou H, Nikolopoulos A, Margaris EP, Donta I, Tsitsika A, Karayiannakos P.
    Antimicrob Agents Chemother; 1997 Sep 01; 41(9):1916-21. PubMed ID: 9303384
    [Abstract] [Full Text] [Related]

  • 11. Contribution of animal models in the search for effective therapy for endocarditis due to enterococci with high-level resistance to gentamicin.
    Eliopoulos GM, Thauvin-Eliopoulos C, Moellering RC.
    Clin Infect Dis; 1992 Jul 01; 15(1):58-62. PubMed ID: 1319757
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy of experimental streptococcal endocarditis. VI. Prevention of enterococcal endocarditis.
    Durack DT, Starkebaum MK, Petersdorf RG.
    J Lab Clin Med; 1977 Jul 01; 90(1):171-9. PubMed ID: 406336
    [No Abstract] [Full Text] [Related]

  • 13. beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis.
    Ingerman M, Pitsakis PG, Rosenberg A, Hessen MT, Abrutyn E, Murray BE, Levison ME.
    J Infect Dis; 1987 Jun 01; 155(6):1226-32. PubMed ID: 3106510
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.
    Gavaldà J, Torres C, Tenorio C, López P, Zaragoza M, Capdevila JA, Almirante B, Ruiz F, Borrell N, Gomis X, Pigrau C, Baquero F, Pahissa A.
    Antimicrob Agents Chemother; 1999 Mar 01; 43(3):639-46. PubMed ID: 10049280
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM.
    Infect Dis Clin North Am; 1993 Mar 01; 7(1):117-33. PubMed ID: 8463648
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.
    Yao JD, Thauvin-Eliopoulos C, Eliopoulos GM, Moellering RC.
    Antimicrob Agents Chemother; 1990 May 01; 34(5):827-30. PubMed ID: 2141778
    [Abstract] [Full Text] [Related]

  • 19. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
    Chambers HF, Kartalija M, Sande M.
    J Infect Dis; 1995 Apr 01; 171(4):897-902. PubMed ID: 7706817
    [Abstract] [Full Text] [Related]

  • 20. Antibiotic prophylaxis against streptomycin-resistant and -susceptible Streptococcus faecalis endocarditis in rabbits.
    Guze PA, Kalmanson GM, Freedman LR, Ishida K, Guze LB.
    Antimicrob Agents Chemother; 1983 Oct 01; 24(4):514-7. PubMed ID: 6418063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.